A Closer Look At Pharmacologic Compounds For Painful Diabetic Peripheral Neuropathy
- Volume 27 - Issue 2 - February 2014
- 8511 reads
- 3 comments
Dr. Rice is an Assistant Clinical Professor in the Department of Orthopedics and Rehabilitation at Yale University School of Medicine. He is in private practice at Fairfield County Foot Surgeons in Norwalk, Conn. He is a Fellow of the American College of Foot and Ankle Surgeons.
Dr. Edgar is the Chief Resident of Podiatric Medicine and Surgery at Yale-New Haven Hospital in New Haven, Conn.
1. Muthuraman A, Singh N, Jaggi AS, Ramesh M. Drug therapy of neuropathic pain: current developtments and future perspectives. Curr Drug Targets 2013 Oct 3 (Epub ahead of print).
2. Anitescu M, Benzon H, Argoff C. Advances in topical analgesics. Curr Opinion in Anaesthesiology. 2013; 26(5):555-561
3. Mick G, Baron R, Finnerup NB, et al. What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Manage 2012; 2:71-77.
4. Argoff CR. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc 2013; 88(2):195-205.
5. Mahoney JM, Vardaxis V. Topical ketamine cream in the treatment of painful diabetic neuropathy: randomized placebo-controlled, double-blind initial study. J Am Podiatr Med Assoc. 2012; 102(3):178-183.
6. Lynch ME. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: randomized, double-blind, placebo-controlled trial. Anesthesiology 2005; 103(1):140-146.